1. M3 Pseudomonas aeruginosa induces inflammation in bronchial epithelial cells via the p38 MAP and Syk tyrosine kinase pathways. (12th November 2019) Authors: Coates, MS; Ito, K; Alton, EWFW; Davies, JC Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P207 Reliability Of Measurements Using Innocor Breath By Breath Analyser During A Maximal Exercise Test In Cystic Fibrosis Patients. (10th November 2014) Authors: Bayfield, KJ; McGovern, M; Simpson, AJ; Embley, M; Cunningham, S; Davies, JC; Alton, EWFW; Innes, JA Journal: Thorax Issue: Volume 69(2014)Supplement 2 Page Start: A167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P209 Standardisation Of Lung Clearance Index In A Multicentre Clinical Trial. (10th November 2014) Authors: Armstrong, DK; Bayfield, KJ; Alton, EWFW; Boyd, AC; Cunningham, S; Elgmati, HI; Gill, DR; Griesenbach, U; Higgins, TE; Hyde, SC; Innes, JA; Saunders, CJ; Spearing, EJ; Davies, JC Journal: Thorax Issue: Volume 69(2014)Supplement 2 Page Start: A168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P249 It is possible to detect active neutrophil elastase in exhaled breath condensate of patients with cystic fibrosis. (15th November 2017) Authors: Edmondson, C; Murphy, R; Moffitt, K; Ribeiro, D; Alton, EWFW; Davies, JC Journal: Thorax Issue: Volume 72(2017)Supplement 3 Page Start: A219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P79 Comparison of CF and Non CF LCI results using the Exhalyzer D and InnocorTM devices. (12th November 2015) Authors: Bayfield, KJ; Saunders, C; Alton, EWFW; Davies, JC Journal: Thorax Issue: Volume 70(2015)Supplement 3 Page Start: A115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P95 Assessment of F/HN-pseudotyped Lentivirus as a Clinically Relevant Vector For Lung Gene Therapy. (19th November 2012) Authors: Griesenbach, U; Inoue, M; Meng, C; Farley, R; Chan, M; Newman, NK; Brum, A; You, J; Kerton, A; Shoemark, A; Boyd, AC; Davies, JC; Higgins, TE; Gill, DR; Hyde, SC; Innes, JA; Porteous, DJ; Hasegawa, M; Alton, EWFW Journal: Thorax Issue: Volume 67(2012)Supplement 2 Page Start: A105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P96 Repeat Administration of GL67A/pGM169 is Feasible, Safe, and Produces Endogenous Levels of CFTR Expression After 12 Doses. (19th November 2012) Authors: Alton, EWFW; Boyd, AC; Cheng, SH; Davies, J; Davies, LA; Dayan, A; Gill, DR; Griesenbach, U; Higgins, T; Hyde, SC; Innes, A; McLachlan, G; Porteous, D; Pringle, IA; Scheule, RK; Sumner-Jones, SG Journal: Thorax Issue: Volume 67(2012)Supplement 2 Page Start: A105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. S103 Anti-Pseudomonal Bacteriophage Cocktail Reduces Inflammatory Responses in the Murine Lung. (19th November 2012) Authors: Pabary, R; Singh, C; Morales, S; Bush, A; Alshafi, K; Bilton, D; Alton, EWFW; Smithyman, A; Davies, JC Journal: Thorax Issue: Volume 67(2012)Supplement 2 Page Start: A50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. S112 Variability in susceptibility to antibiotics and bacteriophages between individual colonies of Pseudomonas aeruginosa from cystic fibrosis sputum samples: implications for future clinical trial design. (12th November 2015) Authors: Khoo, V; Pabary, R; Lund Palau, H; Turnbull, A; Madden, N; Schelenz, S; Jones, A; Morales, S; Alton, EWFW; Davies, JC Journal: Thorax Issue: Volume 70(2015)Supplement 3 Page Start: A64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. S117 RSIV. F/HN-mediated gene therapy enables lungs to produce therapeutically relevant levels of FVIII. (12th November 2015) Authors: Pytel, KM; Paul-Smith, MC; McIntosh, J; Chan, M; Meng, C; Pringle, I; Davis, L; Inoue, M; Hasegawa, M; Hyde, SC; Gill, DR; Nathwani, AC; Alton, EWFW; Griesenbach, U Journal: Thorax Issue: Volume 70(2015)Supplement 3 Page Start: A67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗